Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
34. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific
review. Jama. 2002;288:1889-97.
35. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in
white women. Study of Osteoporotic Fractures Research Group. N Engl J Med.
1995;332:767-73.
36. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness
behavior. Brain Behav Immun. 2007;21:153-60.
37. Dantzer R, Wollman E, Vitkovic L, Yirmiya R. Cytokines and depression:
fortuitous or causative association? Mol Psychiatry. 1999;4:328-32.
38. De la Fuente J. TRH Stimulation and Dexamethasone Suppression in Borderline
Personality Disorder. Biol Psychiatry. 1996;40:412-418.
39. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR.
Serotonin function and the mechanism of antidepressant action. Reversal of
antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen
Psychiatry. 1990;47:411-8.
40. Delmo DM, W;Hauntzinger,M; Wittchen,HU; Kasper,S. Affektive Störungen in
"Diagnostisches und Statistisches Manual Psychiatrischer Störungen" (DSM-IV). Vol. 3
Saß,H; Wittchen, HU; Zaudig,M; 2001.
41. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature.
2006;444:881-7.
42. Dinan TG. Glucocorticoids and the genesis of depressive illness. A
psychobiological model. Br J Psychiatry. 1994;164:365-71.
43. Dinan TG. The physical consequences of depressive illness. Bmj. 1999;318:826.
44. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a
hypothalamic relay: a central control of bone mass. Cell. 2000;100:197-207.
45. Eaton WW, Anthony JC, Gallo J, et al. Natural history of Diagnostic Interview
Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area followup.
Arch Gen Psychiatry. 1997;54:993-9.
63